
After three years at the front of Swedish medtech company Atos Medical, Britt Meelby Jensen has set the date for when she will leave the company, a press release announces.
On March 1, 2022, the former Zealand Pharma CEO steps back from the position in Atos Medical, which Coloplast acquired for EUR 2.2bn in November. The news of Meelby Jensen’s exit is announced on the same day that Coloplast announces that the acquisition has been formally completed, and Atos Medical is now officially a part of the Coloplast group.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app